Letter: a 5‐year long‐term follow‐up study after DAA treatment confirms a reduced HCC risk in a central European cohort of HCV patients with liver cirrhosis. - Ebel, Friederike; Deterding, Katja; Port, Kerstin; Schlevogt, Bernhard; Manns, Michael P.; Maasoumy, Benjamin; Cornberg, Markus; Wedemeyer, Heiner (Alimentary Pharmacology & Therapeutics, 2020)